- Home
- TOMZ vs GDTC Comparison
TOMZ vs GDTC Comparison
Compare TOMZ & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOMZ | GDTC |
|---|---|---|
| Founded | 1979 | 2018 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 15.5M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | TOMZ | GDTC |
|---|---|---|
| Price | $0.70 | $0.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | 16.0K | ★ 41.4K |
| Earning Date | 11-14-2025 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,688,341.00 | $573,193.00 |
| Revenue This Year | N/A | $5.37 |
| Revenue Next Year | $68.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 63.03 |
| 52 Week Low | $0.63 | $0.73 |
| 52 Week High | $1.20 | $3.68 |
Technical Indicators
Market Signals| Indicator | TOMZ | GDTC |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 22.20 |
| Support Level | $0.70 | $0.73 |
| Resistance Level | $0.79 | $1.13 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 54.04 | 10.85 |
Price Performance
Historical ComparisonAbout TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.